MEI Pharma Inc logo

MEI Pharma Inc

NEW
NAS:MEIP (USA)  
$ 2.36 -0.070 (-2.88%) 04:00 PM EST
At Loss
P/B:
0.81
Market Cap:
$ 15.72M
Enterprise V:
$ -22.15M
Volume:
231.00
Avg Vol (2M):
13.58K
Trade In:
Volume:
231.00
At Loss
Avg Vol (2M):
13.58K

Business Description

Description
MEI Pharma Inc is focused on the clinical development of novel therapies for cancer. The company's clinical drug candidate includes Pracinostat, an orally available histone deacetylase inhibitor for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome. Its clinical development portfolio also includes Zandelisib, an oral inhibitor of phosphatidylinositide 3-kinase delta for the treatment of patients with recurrent chronic lymphocytic leukemia or follicular non-Hodgkin's lymphoma; and ME-344, an isoflavone-based mitochondrial inhibitor for the treatment of HER2-negative breast cancer and Pracinostat, an oral histone deacetylase inhibitor. Geographically, all the business activities function through the region of the United States.
Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.94
Interest Coverage No Debt
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 16.78
Quick Ratio 16.78
Cash Ratio 16.54

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -5.8

Financials (Next Earnings Date:2025-09-19 Est.)

MEIP's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:MEIP

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

MEI Pharma Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 65.297
EPS (TTM) ($) -4.75
Beta 0.27
3-Year Sharpe Ratio -0.54
3-Year Sortino Ratio -0.77
Volatility % 49.24
14-Day RSI 55.33
14-Day ATR ($) 0.207112
20-Day SMA ($) 2.31479
12-1 Month Momentum % -21.41
52-Week Range ($) 1.46 - 4.1
Shares Outstanding (Mil) 6.66

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

MEI Pharma Inc Filings

Filing Date Document Date Form
No Filing Data

MEI Pharma Inc Stock Events

Financials Calendars
Event Date Price ($)
No Event Data

MEI Pharma Inc Frequently Asked Questions

What is MEI Pharma Inc(MEIP)'s stock price today?
The current price of MEIP is $2.36. The 52 week high of MEIP is $4.10 and 52 week low is $1.46.
When is next earnings date of MEI Pharma Inc(MEIP)?
The next earnings date of MEI Pharma Inc(MEIP) is 2025-09-19 Est..
Does MEI Pharma Inc(MEIP) pay dividends? If so, how much?
MEI Pharma Inc(MEIP) does not pay dividend.

Guru Commentaries on NAS:MEIP

No articles.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1